Page last updated: 2024-10-21

sk&f 81297 and MPTP Neurotoxicity Syndrome

sk&f 81297 has been researched along with MPTP Neurotoxicity Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vermeulen, RJ2
Drukarch, B2
Sahadat, MC1
Goosen, C1
Wolters, EC1
Stoof, JC2
Andringa, G1
Renier, WO1
Cools, AR1

Other Studies

2 other studies available for sk&f 81297 and MPTP Neurotoxicity Syndrome

ArticleYear
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
    European journal of pharmacology, 1993, Apr-22, Volume: 235, Issue:1

    Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Mac

1993
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.
    Behavioural pharmacology, 1999, Volume: 10, Issue:2

    Topics: Animals; Arm; Behavior, Animal; Benzazepines; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia;

1999